2023 Q4 Form 10-Q Financial Statement

#000155837023019064 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $4.178M $3.479M
YoY Change 16.7% 6.1%
Cost Of Revenue $226.0K $239.0K
YoY Change 0.0% 3.46%
Gross Profit $3.952M $3.240M
YoY Change 17.83% 6.3%
Gross Profit Margin 94.59% 93.13%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $646.0K $670.0K
YoY Change -6.51% -3.18%
% of Gross Profit 16.35% 20.68%
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $5.392M $4.266M
YoY Change 538.86% 723.55%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $4.014M $4.309M
YoY Change -49.67% -33.62%
Income Tax $822.0K $890.0K
% Of Pretax Income 20.48% 20.65%
Net Earnings $3.192M $3.419M
YoY Change -48.37% -34.68%
Net Earnings / Revenue 76.4% 98.28%
Basic Earnings Per Share $0.13 $0.14
Diluted Earnings Per Share $0.13 $0.14
COMMON SHARES
Basic Shares Outstanding 25.98M 25.98M
Diluted Shares Outstanding 25.21M 25.19M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $139.6M $216.5M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $41.11M $41.50M
YoY Change -3.61% -4.21%
Goodwill $10.88M $10.88M
YoY Change 23.64% 23.64%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.853B $1.963B
YoY Change 1.0% -5.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $5.714M $5.800M
YoY Change -3.09%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.714M $5.800M
YoY Change -3.09%
LONG-TERM LIABILITIES
Long-Term Debt $676.0K $700.0K
YoY Change -12.89%
Other Long-Term Liabilities $33.34M $42.80M
YoY Change -2.92% -7.29%
Total Long-Term Liabilities $34.01M $43.50M
YoY Change -3.14% -5.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.714M $5.800M
Total Long-Term Liabilities $34.01M $43.50M
Total Liabilities $1.569B $1.692B
YoY Change -0.99% -7.45%
SHAREHOLDERS EQUITY
Retained Earnings $180.2M $177.0M
YoY Change 10.86% 13.2%
Common Stock $113.7M $113.8M
YoY Change -0.18% -0.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $283.8M $271.8M
YoY Change
Total Liabilities & Shareholders Equity $1.853B $1.963B
YoY Change 1.0% -5.13%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $3.192M $3.419M
YoY Change -48.37% -34.68%
Depreciation, Depletion And Amortization $646.0K $670.0K
YoY Change -6.51% -3.18%
Cash From Operating Activities -$941.0K $12.44M
YoY Change -140.03% 56.5%
INVESTING ACTIVITIES
Capital Expenditures $164.0K $370.0K
YoY Change 1161.54% 469.23%
Acquisitions
YoY Change
Other Investing Activities $37.34M -$38.60M
YoY Change -287.12% -49.82%
Cash From Investing Activities $37.18M -$38.97M
YoY Change -286.17% -49.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -113.1M 92.60M
YoY Change -52.45% -3.39%
NET CHANGE
Cash From Operating Activities -941.0K 12.44M
Cash From Investing Activities 37.18M -38.97M
Cash From Financing Activities -113.1M 92.60M
Net Change In Cash -76.91M 66.07M
YoY Change -69.9% 146.43%
FREE CASH FLOW
Cash From Operating Activities -$941.0K $12.44M
Capital Expenditures $164.0K $370.0K
Free Cash Flow -$1.105M $12.07M
YoY Change -147.26% 53.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25194841
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25143924
CY2023Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001769663
CY2023Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25977679
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25977679
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25194841
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25143924
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q2 us-gaap Finance Lease Liability Statement Of Financial Position Extensible List
FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilities
CY2023Q2 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilities
CY2023Q3 dei Entity Registrant Name
EntityRegistrantName
Pioneer Bancorp, Inc./MD
CY2023Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q3 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#OtherAssets
CY2023Q3 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#OtherLiabilities
CY2023Q2 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#OtherAssets
CY2023Q2 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#OtherLiabilities
CY2023Q3 pbfs Impaired Loans Commercial Valuation Technique Extensible Enumeration
ImpairedLoansCommercialValuationTechniqueExtensibleEnumeration
http://www.pioneerbnk.com/20230930#ValuationTechniqueAppraisalOfCollateralMember
CY2023Q3 pbfs Impaired Loans Commercial Measurement Input Extensible Enumeration
ImpairedLoansCommercialMeasurementInputExtensibleEnumeration
http://www.pioneerbnk.com/20230930#MeasurementInputLiquidationExpenseMember
CY2023Q2 pbfs Impaired Loans Commercial Valuation Technique Extensible Enumeration
ImpairedLoansCommercialValuationTechniqueExtensibleEnumeration
http://www.pioneerbnk.com/20230930#ValuationTechniqueAppraisalOfCollateralMember
CY2023Q2 pbfs Impaired Loans Commercial Measurement Input Extensible Enumeration
ImpairedLoansCommercialMeasurementInputExtensibleEnumeration
http://www.pioneerbnk.com/20230930#MeasurementInputLiquidationExpenseMember
CY2023Q3 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#OtherAssets
CY2023Q3 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#OtherLiabilities
CY2023Q2 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#OtherAssets
CY2023Q2 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2022#OtherLiabilities
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q3 us-gaap Finance Lease Liability Statement Of Financial Position Extensible List
FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilities
CY2023Q3 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilities
CY2023Q3 dei Amendment Flag
AmendmentFlag
false
CY2023Q3 dei Document Type
DocumentType
10-Q
CY2023Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q3 dei Entity File Number
EntityFileNumber
001-38991
CY2023Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-4274253
CY2023Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
652 Albany Shaker Road
CY2023Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Albany
CY2023Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
12211
CY2023Q3 dei City Area Code
CityAreaCode
518
CY2023Q3 dei Local Phone Number
LocalPhoneNumber
730-3025
CY2023Q3 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01
CY2023Q3 dei Trading Symbol
TradingSymbol
PBFS
CY2023Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q3 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q3 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 us-gaap Other Liabilities
OtherLiabilities
39752000
CY2023Q3 us-gaap Liabilities
Liabilities
1691636000
CY2023Q2 us-gaap Liabilities
Liabilities
1589491000
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25977679
CY2023Q3 us-gaap Cash And Due From Banks
CashAndDueFromBanks
83784000
CY2023Q2 us-gaap Cash And Due From Banks
CashAndDueFromBanks
33584000
CY2023Q3 us-gaap Federal Funds Sold
FederalFundsSold
2373000
CY2023Q2 us-gaap Federal Funds Sold
FederalFundsSold
2167000
CY2023Q3 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
130387000
CY2023Q2 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
114727000
CY2023Q3 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
216544000
CY2023Q2 us-gaap Cash Cash Equivalents And Federal Funds Sold
CashCashEquivalentsAndFederalFundsSold
150478000
CY2023Q3 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
412275000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
431667000
CY2023Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
21903000
CY2023Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
21744000
CY2023Q3 us-gaap Debt Securities Held To Maturity Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLoss
23908000
CY2023Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
23949000
CY2023Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
2493000
CY2023Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
2413000
CY2023Q3 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
1234000
CY2023Q2 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
1196000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
1224573000
CY2023Q2 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1166638000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
21069000
CY2023Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
22469000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1203504000
CY2023Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1144169000
CY2023Q3 us-gaap Interest Receivable
InterestReceivable
7124000
CY2023Q2 us-gaap Interest Receivable
InterestReceivable
7194000
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
41455000
CY2023Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
41617000
CY2023Q3 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
16266000
CY2023Q2 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
16322000
CY2023Q3 us-gaap Goodwill
Goodwill
10879000
CY2023Q2 us-gaap Goodwill
Goodwill
8799000
CY2023Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
3351000
CY2023Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
2096000
CY2023Q3 us-gaap Other Assets
OtherAssets
24374000
CY2023Q2 us-gaap Other Assets
OtherAssets
26291000
CY2023Q3 us-gaap Assets
Assets
1963407000
CY2023Q2 us-gaap Assets
Assets
1856191000
CY2023Q3 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
607931000
CY2023Q2 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
526119000
CY2023Q3 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
1030904000
CY2023Q2 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
1015732000
CY2023Q3 us-gaap Deposits
Deposits
1638835000
CY2023Q2 us-gaap Deposits
Deposits
1541851000
CY2023Q3 pbfs Mortgagors Escrow Deposits
MortgagorsEscrowDeposits
3524000
CY2023Q2 pbfs Mortgagors Escrow Deposits
MortgagorsEscrowDeposits
7888000
CY2023Q3 us-gaap Other Liabilities
OtherLiabilities
49277000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25977679
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25977679
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
260000
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
260000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
113491000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
113543000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
176964000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
173038000
CY2023Q3 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
10404000
CY2023Q2 us-gaap Deferred Compensation Equity
DeferredCompensationEquity
10573000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8540000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9568000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
271771000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
266700000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1963407000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1856191000
CY2023Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
16533000
CY2022Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
11513000
CY2023Q3 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
2568000
CY2022Q3 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
1934000
CY2023Q3 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
1055000
CY2022Q3 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
1745000
CY2023Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
20156000
CY2022Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
15192000
CY2023Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
3954000
CY2022Q3 us-gaap Interest Expense Deposits
InterestExpenseDeposits
406000
CY2023Q3 pbfs Interest Expense Borrowings And Other
InterestExpenseBorrowingsAndOther
312000
CY2022Q3 pbfs Interest Expense Borrowings And Other
InterestExpenseBorrowingsAndOther
112000
CY2023Q3 us-gaap Interest Expense
InterestExpense
4266000
CY2022Q3 us-gaap Interest Expense
InterestExpense
518000
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
15890000
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
14674000
CY2023Q3 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
750000
CY2022Q3 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
120000
CY2023Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
15140000
CY2022Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
14554000
CY2023Q3 us-gaap Investment Banking Revenue
InvestmentBankingRevenue
1446000
CY2022Q3 us-gaap Investment Banking Revenue
InvestmentBankingRevenue
1570000
CY2023Q3 us-gaap Insurance Services Revenue
InsuranceServicesRevenue
1981000
CY2022Q3 us-gaap Insurance Services Revenue
InsuranceServicesRevenue
1734000
CY2023Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
80000
CY2022Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-39000
CY2023Q3 pbfs Bank Owned Life Insurance Income Expense
BankOwnedLifeInsuranceIncomeExpense
-56000
CY2022Q3 pbfs Bank Owned Life Insurance Income Expense
BankOwnedLifeInsuranceIncomeExpense
461000
CY2023Q3 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
123000
CY2022Q3 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
79000
CY2023Q3 us-gaap Noninterest Income
NoninterestIncome
3574000
CY2022Q3 us-gaap Noninterest Income
NoninterestIncome
3805000
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6923000
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6592000
CY2023Q3 us-gaap Occupancy Net
OccupancyNet
1831000
CY2022Q3 us-gaap Occupancy Net
OccupancyNet
1711000
CY2023Q3 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1189000
CY2022Q3 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1037000
CY2023Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
141000
CY2022Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
141000
CY2023Q3 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
239000
CY2022Q3 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
231000
CY2023Q3 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
262000
CY2022Q3 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
171000
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
2587000
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
773000
CY2023Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1233000
CY2022Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1212000
CY2023Q3 us-gaap Noninterest Expense
NoninterestExpense
14405000
CY2022Q3 us-gaap Noninterest Expense
NoninterestExpense
11868000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4309000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6491000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
890000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1257000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
3419000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
5234000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25194841
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25143924
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
3419000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
5234000
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1391000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-8496000
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
1391000
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-8496000
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
363000
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-2222000
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1028000
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-6274000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1028000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6274000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4447000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1040000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
242627000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
5234000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6274000
CY2022Q3 pbfs Employee Stock Ownership Plan Shares Committed To Be Released
EmployeeStockOwnershipPlanSharesCommittedToBeReleased
12729
CY2022Q3 us-gaap Amortization Of Esop Award
AmortizationOfESOPAward
122000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
241709000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
266700000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
3419000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1028000
CY2023Q3 pbfs Employee Stock Ownership Plan Shares Committed To Be Released
EmployeeStockOwnershipPlanSharesCommittedToBeReleased
12729
CY2023Q3 us-gaap Amortization Of Esop Award
AmortizationOfESOPAward
117000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
271771000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
3419000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
5234000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
671000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
692000
CY2023Q3 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
750000
CY2022Q3 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
120000
CY2023Q3 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
370000
CY2022Q3 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-268000
CY2023Q3 us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
117000
CY2022Q3 us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
122000
CY2023Q3 pbfs Bank Owned Life Insurance Income Expense
BankOwnedLifeInsuranceIncomeExpense
-56000
CY2022Q3 pbfs Bank Owned Life Insurance Income Expense
BankOwnedLifeInsuranceIncomeExpense
461000
CY2022Q3 pbfs Proceeds From Sale Of Loans
ProceedsFromSaleOfLoans
100000
CY2022Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
2000
CY2023Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
80000
CY2022Q3 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-39000
CY2023Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
37000
CY2022Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
243000
CY2023Q3 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-70000
CY2022Q3 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1272000
CY2023Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
156000
CY2022Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1738000
CY2023Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
7920000
CY2022Q3 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
4624000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
8000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
6000
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12442000
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7975000
CY2023Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
45077000
CY2022Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
39329000
CY2023Q3 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
23924000
CY2022Q3 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
80173000
CY2023Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
1617000
CY2022Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
1630000
CY2023Q3 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
1576000
CY2022Q3 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
1527000
CY2023Q3 us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
38000
CY2022Q3 us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
35000
CY2023Q3 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
57774000
CY2022Q3 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
37288000
CY2023Q3 pbfs Payments To Acquire Property Plant And Equipment Net
PaymentsToAcquirePropertyPlantAndEquipmentNet
373000
CY2022Q3 pbfs Payments To Acquire Property Plant And Equipment Net
PaymentsToAcquirePropertyPlantAndEquipmentNet
65000
CY2022Q3 us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
1143000
CY2023Q3 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
1980000
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-38971000
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-76986000
CY2023Q3 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
96984000
CY2022Q3 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
98739000
CY2023Q3 pbfs Increase Decrease In Mortgagors Escrow Deposits
IncreaseDecreaseInMortgagorsEscrowDeposits
-4364000
CY2022Q3 pbfs Increase Decrease In Mortgagors Escrow Deposits
IncreaseDecreaseInMortgagorsEscrowDeposits
-2894000
CY2023Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
25000
CY2022Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
25000
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
92595000
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
95820000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
66066000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
26809000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
150478000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
376060000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
216544000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
402869000
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
4280000
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
503000
CY2023Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1000000
CY2022Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
900000
CY2023Q3 pbfs Acquisition Contingent Consideration Payable
AcquisitionContingentConsiderationPayable
1499000
CY2022Q3 pbfs Non Cash Right Of Use Assets
NonCashRightOfUseAssets
6535000
CY2022Q3 pbfs Non Cash Lease Liabilities
NonCashLeaseLiabilities
6883000
CY2023Q3 pbfs Number Of Offices In Capital Region
NumberOfOfficesInCapitalRegion
23
CY2023Q3 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ substantially from those estimates. The allowance for credit losses, valuation of securities and other financial instruments, the funded status and expense of employee benefit plans, legal proceedings and other contingent liabilities, and the realizability of deferred tax assets are particularly subject to change.</p>
CY2023Q3 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Reclassifications</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Amounts in the prior period’s consolidated financial statements are reclassified whenever necessary to conform to the current period’s presentation.</p>
CY2023Q3 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
429434000
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
309000
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
17468000
CY2023Q3 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
412275000
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
450217000
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
320000
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
18870000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
431667000
CY2023Q3 pbfs Debt Securities Available For Sale Accrued Interest
DebtSecuritiesAvailableForSaleAccruedInterest
1900000
CY2023Q3 us-gaap Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
0
CY2023Q3 us-gaap Debt Securities Held To Maturity Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLoss
23908000
CY2023Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
2005000
CY2023Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
21903000
CY2023Q2 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
23949000
CY2023Q2 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
2205000
CY2023Q2 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
21744000
CY2023Q3 pbfs Debt Securities Held To Maturity Accrued Interest
DebtSecuritiesHeldToMaturityAccruedInterest
159000
CY2023Q3 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesHeldToMaturityAllowanceForCreditLossExcludingAccruedInterest
0
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
85399000
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
409000
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
326503000
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
17059000
CY2023Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
411902000
CY2023Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
17468000
CY2023Q3 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
21903000
CY2023Q3 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
2005000
CY2023Q3 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue
21903000
CY2023Q3 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
2005000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
151940000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
2043000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
268889000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
16827000
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
420829000
CY2023Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
18870000
CY2023Q2 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
21744000
CY2023Q2 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
2205000
CY2023Q2 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue
21744000
CY2023Q2 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
2205000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
131439000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
129073000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
297748000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
282715000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
247000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
487000
CY2023Q3 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss
429434000
CY2023Q3 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
412275000
CY2023Q3 us-gaap Debt Securities Held To Maturity Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss Maturity Allocated And Single Maturity Date Year One
DebtSecuritiesHeldToMaturityAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateYearOne
2391000
CY2023Q3 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
2256000
CY2023Q3 us-gaap Debt Securities Held To Maturity Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year One Through Five
DebtSecuritiesHeldToMaturityAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughFive
1517000
CY2023Q3 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
1517000
CY2023Q3 us-gaap Debt Securities Held To Maturity Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss Maturity Allocated And Single Maturity Date After Year5 Through10
DebtSecuritiesHeldToMaturityAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLossMaturityAllocatedAndSingleMaturityDateAfterYear5Through10
20000000
CY2023Q3 us-gaap Held To Maturity Securities Debt Maturities After Five Through Ten Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
18130000
CY2023Q3 us-gaap Debt Securities Held To Maturity Excluding Accrued Interest Before Allowance For Credit Loss
DebtSecuritiesHeldToMaturityExcludingAccruedInterestBeforeAllowanceForCreditLoss
23908000
CY2023Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
21903000
CY2022Q3 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2023Q3 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0
CY2022Q3 us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
0
CY2023Q3 us-gaap Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
0
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
792000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
21677000
CY2023Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
22469000
CY2023Q2 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
11544000
CY2023Q2 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
1155094000
CY2022Q3 pbfs Proceeds From Sale Of Equity Securities
ProceedsFromSaleOfEquitySecurities
0
CY2023Q3 pbfs Proceeds From Sale Of Equity Securities
ProceedsFromSaleOfEquitySecurities
0
CY2023Q3 pbfs Available For Sale Securities Pledged To Secure Federal Home Loan Bank New York Advances And Municipal Deposits
AvailableForSaleSecuritiesPledgedToSecureFederalHomeLoanBankNewYorkAdvancesAndMunicipalDeposits
407200000
CY2023Q2 pbfs Available For Sale Securities Pledged To Secure Federal Home Loan Bank New York Advances And Municipal Deposits
AvailableForSaleSecuritiesPledgedToSecureFederalHomeLoanBankNewYorkAdvancesAndMunicipalDeposits
428500000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
1224573000
CY2023Q2 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1166638000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
21069000
CY2023Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
22469000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1203504000
CY2023Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1144169000
CY2023Q3 pbfs Financing Receivable Accrued Interest
FinancingReceivableAccruedInterest
5000000.0
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
22469000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
916000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
35000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery
30000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
21069000
CY2023Q3 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
-166000
CY2023Q3 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
1458000
CY2023Q2 pbfs Total Allowance For Credit Losses
TotalAllowanceForCreditLosses
22469000
CY2023Q3 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
750000
CY2023Q3 pbfs Total Allowance For Credit Losses Writeoff
TotalAllowanceForCreditLossesWriteoff
35000
CY2023Q3 pbfs Total Allowance For Credit Losses Recovery
TotalAllowanceForCreditLossesRecovery
30000
CY2023Q3 pbfs Total Allowance For Credit Losses
TotalAllowanceForCreditLosses
22527000
CY2022Q2 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
22524000
CY2022Q3 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
120000
CY2022Q3 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
-129000
CY2022Q3 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
54000
CY2022Q3 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
22569000
CY2023Q3 pbfs Financing Receivable Allowance For Credit Loss Individually Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossIndividuallyEvaluatedForImpairment
785000
CY2023Q3 pbfs Financing Receivable Allowance For Credit Loss Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossCollectivelyEvaluatedForImpairment
20284000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
21069000
CY2023Q3 pbfs Financing Receivables Individually Evaluated For Impairment
FinancingReceivablesIndividuallyEvaluatedForImpairment
11344000
CY2023Q3 pbfs Financing Receivables Collectively Evaluated For Impairment
FinancingReceivablesCollectivelyEvaluatedForImpairment
1213229000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
1224573000
CY2023Q2 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1166638000
CY2023Q2 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
11572000
CY2023Q2 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
11544000
CY2023Q2 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
792000
CY2023 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
11812000
CY2023 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
168000
CY2022Q3 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
0
CY2022Q3 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
0
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Nonaccrual
FinancingReceivableExcludingAccruedInterestNonaccrual
14406000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Nonaccrual No Allowance
FinancingReceivableExcludingAccruedInterestNonaccrualNoAllowance
7830000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest90 Days Or More Past Due Still Accruing
FinancingReceivableExcludingAccruedInterest90DaysOrMorePastDueStillAccruing
15000
CY2023Q2 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
14235000
CY2023Q2 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
3531000
CY2023Q3 pbfs Financing Receivable Collateral Dependent Amount
FinancingReceivableCollateralDependentAmount
11344000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
1224573000
CY2023Q2 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1166638000
CY2023Q3 us-gaap Insurance Recoveries
InsuranceRecoveries
576000
pbfs Additional Recoveries On Charge Off Of Loans
AdditionalRecoveriesOnChargeOffOfLoans
0
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
363000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-2222000
CY2023Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
363000
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-2222000
CY2023Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
363000
CY2022Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-2222000
CY2023Q3 pbfs Fair Value Disclosure Off Balance Sheet Risks Face Amount Liability Bearing Fixed Interest Rate
FairValueDisclosureOffBalanceSheetRisksFaceAmountLiabilityBearingFixedInterestRate
17478000
CY2023Q3 pbfs Fair Value Disclosure Off Balance Sheet Risks Face Amount Liability Bearing Variable Interest Rate
FairValueDisclosureOffBalanceSheetRisksFaceAmountLiabilityBearingVariableInterestRate
298173000
CY2023Q3 us-gaap Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability
FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability
315651000
CY2023Q2 pbfs Fair Value Disclosure Off Balance Sheet Risks Face Amount Liability Bearing Fixed Interest Rate
FairValueDisclosureOffBalanceSheetRisksFaceAmountLiabilityBearingFixedInterestRate
20541000
CY2023Q2 pbfs Fair Value Disclosure Off Balance Sheet Risks Face Amount Liability Bearing Variable Interest Rate
FairValueDisclosureOffBalanceSheetRisksFaceAmountLiabilityBearingVariableInterestRate
305460000
CY2023Q2 us-gaap Fair Value Disclosure Offbalance Sheet Risks Face Amount Liability
FairValueDisclosureOffbalanceSheetRisksFaceAmountLiability
326001000
CY2023Q3 pbfs Adjustable Rate Residential Mortgage Loans Interest Rate Caps Amount
AdjustableRateResidentialMortgageLoansInterestRateCapsAmount
184000000.0
CY2023Q3 pbfs Adjustable Rate Mortgage Loans Conversion Options
AdjustableRateMortgageLoansConversionOptions
560000
CY2023Q3 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
0
CY2023Q2 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
0
CY2023Q3 pbfs Loan Commitments With Rate Lock Agreements Held For Sale
LoanCommitmentsWithRateLockAgreementsHeldForSale
0
CY2023Q2 pbfs Loan Commitments With Rate Lock Agreements Held For Sale
LoanCommitmentsWithRateLockAgreementsHeldForSale
0
CY2023Q3 pbfs Commitments To Sell Loans To Unrelated Investors
CommitmentsToSellLoansToUnrelatedInvestors
0
CY2023Q2 pbfs Commitments To Sell Loans To Unrelated Investors
CommitmentsToSellLoansToUnrelatedInvestors
0
CY2022Q3 pbfs Litigation Related Expense
LitigationRelatedExpense
0
CY2023Q3 pbfs Litigation Related Expense
LitigationRelatedExpense
0
CY2019Q3 pbfs Potential Exposure For Fraudulent Activity Deposit Activity
PotentialExposureForFraudulentActivityDepositActivity
18500000
CY2019Q3 pbfs Potential Fraudulent Activity With Deposit Account Set Off
PotentialFraudulentActivityWithDepositAccountSetOff
16000000.0
CY2019Q3 pbfs Potential Fraudulent Activity With Deposit Account Set Off Overdrafts Negative Accounts
PotentialFraudulentActivityWithDepositAccountSetOffOverdraftsNegativeAccounts
15600000
CY2019Q3 pbfs Potentially Fraudulent Activity Deposit Activity Non Interest Expense
PotentiallyFraudulentActivityDepositActivityNonInterestExpense
2500000
pbfs Additional Charges On Non Interest Expense
AdditionalChargesOnNonInterestExpense
0
CY2019Q3 pbfs Potential Exposure For Fraudulent Activity Lending Activity
PotentialExposureForFraudulentActivityLendingActivity
15800000
CY2019Q3 pbfs Potential Fraudulent Activity With Established Business Customer Amount Of Commercial Loan Relationships Originating Lender
PotentialFraudulentActivityWithEstablishedBusinessCustomerAmountOfCommercialLoanRelationshipsOriginatingLender
35800000
CY2019Q2 pbfs Potential Fraudulent Activity Provision For Loan Losses
PotentialFraudulentActivityProvisionForLoanLosses
15800000
CY2020Q1 pbfs Potential Fraudulent Activity Partial Recovery Related To Charge Off Of Commercial Loan Relationships
PotentialFraudulentActivityPartialRecoveryRelatedToChargeOffOfCommercialLoanRelationships
1700000
CY2020Q3 pbfs Potential Fraudulent Activity Partial Recovery Related To Charge Off Of Commercial Loan Relationships
PotentialFraudulentActivityPartialRecoveryRelatedToChargeOffOfCommercialLoanRelationships
34000
pbfs Additional Charge On Provision For Loan Losses
AdditionalChargeOnProvisionForLoanLosses
0
CY2022Q3 us-gaap Insurance Recoveries
InsuranceRecoveries
542000
CY2021Q2 pbfs Bank S Interest In Cash And Securities In Which Petition Was Filed To Adjudicate Validity
BankSInterestInCashAndSecuritiesInWhichPetitionWasFiledToAdjudicateValidity
14900000
CY2023Q3 pbfs Maximum Potential Monetary Penalties Related To Regulatory Investigation
MaximumPotentialMonetaryPenaltiesRelatedToRegulatoryInvestigation
30000000.0
CY2023Q3 pbfs Amount Of Potential Monetary Penalties Related To Damages Sought By Plaintiffs In Specific Legal Proceedings
AmountOfPotentialMonetaryPenaltiesRelatedToDamagesSoughtByPlaintiffsInSpecificLegalProceedings
15000000.0
CY2023Q3 pbfs Impaired Loans Commercial
ImpairedLoansCommercial
539000
CY2023Q2 pbfs Impaired Loans Commercial
ImpairedLoansCommercial
539000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3479000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3279000
CY2023Q3 us-gaap Revenue Not From Contract With Customer Excluding Interest Income
RevenueNotFromContractWithCustomerExcludingInterestIncome
95000
CY2022Q3 us-gaap Revenue Not From Contract With Customer Excluding Interest Income
RevenueNotFromContractWithCustomerExcludingInterestIncome
526000
CY2023Q3 us-gaap Noninterest Income
NoninterestIncome
3574000
CY2022Q3 us-gaap Noninterest Income
NoninterestIncome
3805000
CY2023Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
583000
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
608000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5547000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5448000
CY2023Q3 pbfs Right Of Use Assets
RightOfUseAssets
6130000
CY2023Q2 pbfs Right Of Use Assets
RightOfUseAssets
6056000
CY2023Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
693000
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
711000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
5817000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
5713000
CY2023Q3 pbfs Lease Liabilities
LeaseLiabilities
6510000
CY2023Q2 pbfs Lease Liabilities
LeaseLiabilities
6424000
CY2023Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P67Y2M12D
CY2023Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P64Y10M24D
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P13Y9M18D
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P14Y2M12D
CY2023Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0566
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0562
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0390
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0387
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
25000
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
25000
CY2023Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
8000
CY2022Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
8000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
159000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
151000
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
51000
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
50000
CY2023Q3 us-gaap Lease Cost
LeaseCost
243000
CY2022Q3 us-gaap Lease Cost
LeaseCost
234000
CY2023Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
25000
CY2022Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
25000
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
151000
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
145000
CY2023Q3 us-gaap Finance Lease Liability Payments Due In Next Rolling Twelve Months
FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths
131000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
636000
CY2023Q3 us-gaap Finance Lease Liability Payments Due In Rolling Year Two
FinanceLeaseLiabilityPaymentsDueInRollingYearTwo
117000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
628000
CY2023Q3 us-gaap Finance Lease Liability Payments Due In Rolling Year Three
FinanceLeaseLiabilityPaymentsDueInRollingYearThree
30000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
593000
CY2023Q3 us-gaap Finance Lease Liability Payments Due In Rolling Year Four
FinanceLeaseLiabilityPaymentsDueInRollingYearFour
30000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
578000
CY2023Q3 us-gaap Finance Lease Liability Payments Due In Rolling Year Five
FinanceLeaseLiabilityPaymentsDueInRollingYearFive
30000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
573000
CY2023Q3 us-gaap Finance Lease Liability Payments Due In Rolling After Year Five
FinanceLeaseLiabilityPaymentsDueInRollingAfterYearFive
2580000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
4587000
CY2023Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
2918000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
7595000
CY2023Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
2225000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1778000
CY2023Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
693000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
5817000
CY2022Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
CY2023Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
3419000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
5234000
CY2023Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
25977679
CY2022Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
25977679
CY2023Q3 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
782838
CY2022Q3 us-gaap Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released
WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased
833755
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25194841
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25143924
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21

Files In Submission

Name View Source Status
pbfs-20230930_cal.xml Edgar Link unprocessable
0001558370-23-019064-index-headers.html Edgar Link pending
0001558370-23-019064-index.html Edgar Link pending
0001558370-23-019064.txt Edgar Link pending
0001558370-23-019064-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pbfs-20230930.xsd Edgar Link pending
pbfs-20230930x10q.htm Edgar Link pending
pbfs-20230930xex31d1.htm Edgar Link pending
pbfs-20230930xex31d2.htm Edgar Link pending
pbfs-20230930xex32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
pbfs-20230930_def.xml Edgar Link unprocessable
pbfs-20230930_lab.xml Edgar Link unprocessable
pbfs-20230930_pre.xml Edgar Link unprocessable
pbfs-20230930x10q_htm.xml Edgar Link completed
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable